HomeSecurityAttack on Dr. Reddy's highlights the importance of better infrastructure

The attack on Dr. Reddy's highlights the importance of better infrastructure

As we mentioned in our previous article, last week the pharmaceutical company Dr. Reddy's temporarily stopped production at all its laboratories due to a breach in servers .

Dr. Reddy's

The incident occurred shortly after the company received approval from DCGI to conduct phase 2 and 3 trials for a redesigned protocol for a COVID-19.

attack the healthcare system is to cyberattacks.

According to a report by HSBC, damage control and recovery are crucial. It said that Dr. Reddy's is the first company among its peers in terms of investing in digital transformation initiatives as well as innovative cybersecurity technologies.

"The attack came as a stark reminder to strengthen its digital infrastructure and enhance cybersecurity control measures. While it does not expect significant operational impacts, a rapid update on damage control and restoration of operations will in our opinion be critical to validating the resilience of its systems," the report added.

The company is currently reviewing its security practices to make them more effective and is trying to identify how the breach.

The attack on Dr. Reddy's highlights the importance of better infrastructure

"After detecting a cyber attack, we have isolated all data center services to take the required preventive actions. We expect all services to be operational within 24 hours and do not anticipate any significant impact on our operations due to this incident," said Mukesh Rathi, CIO at Dr. Reddy's Labs.

The company suffered data breaches on its servers in the UK, US, India, Brazil and Russia.

In an era when the transition to the digital world is more intense than ever, attacks like this are a worrying phenomenon and highlight the importance of having a more secure infrastructure.  

“The risk of cyberattacks in the pharmaceutical industry is further amplified by remote working during the COVID-19 pandemic. Thus, pharmaceutical manufacturers (including DRRD) need to further invest in and strengthen cybersecurity systems to avoid or minimize operational disruptions, high audit costs, and limit losses and any potential lawsuits or regulatory sanctions,” the report said.

📧
Subscribe to the SecNews Newsletter

The most important Security & Technology news in your Inbox.

Absentee Mia
Absentee Miahttps://www.secnews.gr/politiki-syntaxis/
Member of the Editorial Team of SecNews. He writes about cybersecurity, online fraud, privacy and technology. All articles follow the SecNews Editorial Policy.

SEARCH

FOLLOW US

📧
Newsletter SecNews
The most important Security & Technology news in your inbox.

LIVE NEWS